These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32945488)
1. Single immunoglobulin and Toll‑interleukin‑1 receptor domain containing molecule protects against severe acute pancreatitis in vitro by negatively regulating the Toll‑like receptor‑4 signaling pathway: A clinical and experimental study. Zhao R; Song C; Liu L; Liu Q; Zhou N; Zhou X; Xie Y Mol Med Rep; 2020 Oct; 22(4):2851-2859. PubMed ID: 32945488 [TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3‑kinase/protein kinase B regulates inflammation severity via signaling of Toll‑like receptor 4 in severe acute pancreatitis. Wang J; Zhang C; Xu P; Yang ZW; Weng CZ; Lai YX Mol Med Rep; 2018 Jun; 17(6):7835-7844. PubMed ID: 29620213 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils. Ueno-Shuto K; Kato K; Tasaki Y; Sato M; Sato K; Uchida Y; Sakai H; Ono T; Suico MA; Mitsutake K; Tokutomi N; Kai H; Shuto T J Biol Chem; 2014 Jun; 289(26):18097-109. PubMed ID: 24821721 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Tim-3 reduces Helicobacter pylori-associated inflammation through TLR4/NFκB signaling in vitro. Wang F; Mao Z; Liu D; Yu J; Wang Y; Ye W; Lin D; Zhou N; Xie Y Mol Med Rep; 2017 May; 15(5):3252-3258. PubMed ID: 28339054 [TBL] [Abstract][Full Text] [Related]
5. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. Huang X; Hazlett LD; Du W; Barrett RP J Immunol; 2006 Jul; 177(1):548-56. PubMed ID: 16785552 [TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation. Liu J; Chen Y; Liu D; Liu W; Hu S; Zhou N; Xie Y Immunol Lett; 2017 Mar; 183():52-61. PubMed ID: 28153604 [TBL] [Abstract][Full Text] [Related]
7. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350 [TBL] [Abstract][Full Text] [Related]
8. Anti-Inflamm-Aging Effects of Long-Term Caloric Restriction via Overexpression of SIGIRR to Inhibit NF-κB Signaling Pathway. Xu XM; Ning YC; Wang WJ; Liu JQ; Bai XY; Sun XF; Cai GY; Chen XM Cell Physiol Biochem; 2015; 37(4):1257-70. PubMed ID: 26431348 [TBL] [Abstract][Full Text] [Related]
9. Single-Immunoglobulin Interleukin-1-Related Receptor regulates vulnerability to TLR4-mediated necrotizing enterocolitis in a mouse model. Fawley J; Cuna A; Menden HL; McElroy S; Umar S; Welak SR; Gourlay DM; Li X; Sampath V Pediatr Res; 2018 Jan; 83(1-1):164-174. PubMed ID: 28846670 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973 [TBL] [Abstract][Full Text] [Related]
11. Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro. Tian F; Lu Q; Lei J; Ni Y; Xie N; Zhong D; Yang G; Si S; Jiang T J Immunol Res; 2020; 2020():5097920. PubMed ID: 33123603 [TBL] [Abstract][Full Text] [Related]
12. SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells. Zhang C; Wu X; Zhao Y; Deng Z; Qian G Mol Biol Rep; 2011 Jan; 38(1):601-9. PubMed ID: 20364327 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of IL-23 production in M1 macrophages by TIR8/SIGIRR through TLR4- or TLR7/8-mediated signaling. Yamaguchi R; Sakamoto A; Yamamoto T; Narahara S; Sugiuchi H; Yamaguchi Y Cytokine; 2017 Nov; 99():310-315. PubMed ID: 28869081 [TBL] [Abstract][Full Text] [Related]
14. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. Qin J; Qian Y; Yao J; Grace C; Li X J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876 [TBL] [Abstract][Full Text] [Related]
15. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice. Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057 [TBL] [Abstract][Full Text] [Related]
16. Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Feng T; Yunfeng N; Jinbo Z; Zhipei Z; Huizhong Z; Li L; Tao J; Yunjie W Chem Biol Interact; 2010 Feb; 183(3):442-9. PubMed ID: 19948160 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. Skuginna V; Lech M; Allam R; Ryu M; Clauss S; Susanti HE; Römmele C; Garlanda C; Mantovani A; Anders HJ PLoS One; 2011 Apr; 6(4):e19204. PubMed ID: 21544241 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. Costello DA; Watson MB; Cowley TR; Murphy N; Murphy Royal C; Garlanda C; Lynch MA J Neurosci; 2011 Mar; 31(10):3871-9. PubMed ID: 21389242 [TBL] [Abstract][Full Text] [Related]
19. SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells. Li D; Zhang X; Chen B BMC Immunol; 2015 Dec; 16():73. PubMed ID: 26634342 [TBL] [Abstract][Full Text] [Related]
20. A novel binding protein of single immunoglobulin IL-1 receptor-related molecule: Paralemmin-3. Chen X; Wu X; Zhao Y; Wang G; Feng J; Li Q; Qian G Biochem Biophys Res Commun; 2011 Jan; 404(4):1029-33. PubMed ID: 21187075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]